{"id":"NCT00985985","sponsor":"GlaxoSmithKline","briefTitle":"Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation","officialTitle":"A Multi-center, Randomized, Double-blind, Parallel, Placebo-controlled Clinical Study to Evaluate Efficacy and Safety of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-05","primaryCompletion":"2011-03","completion":"2011-03","firstPosted":"2009-09-29","resultsPosted":"2014-06-16","lastUpdate":"2014-06-27"},"enrollment":723,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Smoking"],"interventions":[{"type":"DRUG","name":"Nicotine","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"2mg nicotine lozenge","type":"EXPERIMENTAL"},{"label":"2 mg placebo","type":"PLACEBO_COMPARATOR"},{"label":"4 mg nicotine lozenge","type":"EXPERIMENTAL"},{"label":"4 mg placebo","type":"PLACEBO_COMPARATOR"}],"summary":"A multi-center, randomized, double-blind, placebo-controlled, 4-arm clinical study to evaluate efficacy and safety of nicotine lozenge (2mg and 4mg) in smoking cessation in adult cigarette smokers who are motivated to quit smoking. Successful quitters or participants who smoke occasionally will be followed up after week 24 till 12 months.","primaryOutcome":{"measure":"Rate of Successful Smoking Cessation at Week 6","timeFrame":"From baseline to Week 6","effectByArm":[{"arm":"Nicotine Lozenge 2 mg (Low Dependence Smokers)","deltaMin":24.48,"sd":null},{"arm":"Placebo Lozenge (Low Dependence Smokers)","deltaMin":21.49,"sd":null},{"arm":"Nicotine Lozenge 4 mg (High Dependence Smokers)","deltaMin":30.83,"sd":null},{"arm":"Placebo Lozenge (High Dependence Smokers)","deltaMin":20.17,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.3851"},{"comp":"OG002 vs OG003","p":"0.0565"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":16},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["34611902"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":241},"commonTop":["Upper Respiratory Tract Infection","Nasopharyngitis","Nausea","Dyspnoea"]}}